INFECTIOUS DISEASES & VACCINES - COVID-19
As always, Janssen remains committed to healthcare professionals and patients, as well as to our employees and communities
WHAT IS JANSSEN DOING TO FIGHT THIS PANDEMIC?
Screen a library of antiviral molecules in collaboration with partners.
To help identify potential treatments for the virus.
Collaborate with regulators, healthcare organisations, institutions and communities worldwide
To help ensure our research platforms, existing science and outbreak expertise can be maximized to stem this public health threat.
WHAT IMPACT DOES COVID-19 HAVE ON US AS A COMPANY?
At Johnson & Johnson we’ve worked out a robust continuity plan to avoid disruption to our business
Learn moreWe highly value our employees, their health, and the health of their families. Find out how we commit to keeping our colleagues safe
Learn moreThe latest updates
Biopharma Leaders Unite To Stand With Science
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
Follow all latest updates via LinkedIn and Twitter
Back to Respiratory infections